发明名称 |
CRYSTALLINE SOLID AND AMORPHOUS FORMS OF (-)- HALOFENATE AND METHODS RELATED THERETO |
摘要 |
The present invention provides crystalline solid and amorphous forms of (-)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of conditions associated with blood lipid deposition in a mammal, particularly those diseases related to Type 2 diabetes and hyperlipidemia. The invention also relates to a method for preventing or treating Type 2 diabetes and hyperlipidemia in a mammal comprising the step of administering a therapeutically effective amount of crystalline solid and amorphous forms of (-)-halofenate. |
申请公布号 |
CA2606279(C) |
申请公布日期 |
2015.01.06 |
申请号 |
CA20062606279 |
申请日期 |
2006.04.20 |
申请人 |
METABOLEX, INC. |
发明人 |
DAUGS, EDWARD D.;HAGEN, ERIC J.;HANKO, JASON A.;LOUKS, DAVID H. |
分类号 |
C07C233/18;A61K31/216;A61P3/06;A61P3/10;C07C231/24 |
主分类号 |
C07C233/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|